AccuStem Sciences, Inc.(ACUT.US)

Company Encyclopedia

AccuStem Sciences, Inc.

ACUT.US

AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care. It offers MSC test, a 24-micro RNA (miRNA) assay designed to help determine whether lung nodules identified by low dose computer tomography screening are benign or malignant. The company also provides StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company has a partnership with EmeritusDX for the development of non-invasive blood testing technologies.

1.896 T

ACUT.USMarket value -Rank by Market Cap -/-

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
Gabriele Marco Antonio Cerrone	20.5%	No Change	13/06/2025
Panetta Partners Limited	19.96%	No Change	13/06/2025
Tiziana Life Sciences Ltd	8.32%	No Change	31/12/2024
Willy Jules Simon	0.06%	No Change	31/12/2024
Wendy E. Blosser	0.01%	No Change	31/12/2024
Keeren Shah	0%	No Change	31/12/2024

News

AI Hardware Takes Center Stage as CES 2026 Opens Next Week — What to Watch For

The 2026 International Consumer Electronics Show (CES) is set to take place from January 6 to 9 in Las Vegas, focusing heavily on artificial intelligence (AI). Analysts predict a significant consumer AI revolution, with major companies like NVIDIA and AMD showcasing advancements in AI hardware. Robotics and smart glasses will also be highlighted, with LG and Agility Robotics presenting new models. Additionally, TV technology will see competition among brands like TCL and Sony, while Intel and AMD will unveil next-gen processors for laptops. CES 2026 will also feature innovations in automotive tech, digital health, and sustainable energy solutions.

TradingKey·4 Hours ago

TradingKey·4 Hours ago

The global mHealth Technologies market to reach $201.1 billion by 2030 from $91.4 billion in 2025, with a 17.1% CAGR.

Dublin—A recent report on Mobile Health (mHealth) Technologies has become available through ResearchAndMarkets.com. The global market for mHealth Technologies is predicted to increase from $91.4 billion in 2025 to a projected $201.1 billion by 2030, showcasing a compound annual growth rate (CAGR) of 17.1% between 2025 and 2030. The growth of the mHealth technologies market is being driven by advancements like AI.

Unusual Whales·12/31/2025 22:29